📊 Market Insights: January 2026 IQVIA

Описание: 📊 Market Insights: January 2026

IQVIA’s latest report reveals impressive growth trends in the pharmaceutical sector. Key takeaways:

🔹 Market Growth: TSA and SSA markets show strong growth, with TSA valued at Rs. 252,067 Cr and SSA at Rs. 211,351 Cr in January 2026.

🔹 Top Performers: Cardiac & Diabetes therapies led the way, with significant growth observed in key brands like Mounjaro and Foracort.

🔹 Company Trends: Sun continues to dominate, but we saw strong movements from companies like Intas, Lupin, and Torrent.

🔹 Therapy Growth: Chronic therapies outpaced acute therapies with a robust 16% growth in January.

📅 Looking ahead: The market is on a positive trajectory, driven by innovation and strong player performances.

#IQVIA #Pharmaceuticals #MarketGrowth #Healthcare #PharmaTrends #IndiaHealthcare